Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

VIRI | Virios Therapeutics Inc

Index- P/E- EPS (ttm)-0.55 Insider Own25.15% Shs Outstand18.33M Perf Week-1.62%
Market Cap17.80M Forward P/E- EPS next Y-0.28 Insider Trans0.84% Shs Float14.41M Perf Month-24.20%
Income-7.58M PEG- EPS next Q-0.09 Inst Own4.06% Short Float / Ratio2.90% / 0.71 Perf Quarter-32.99%
Sales0.00M P/S- EPS this Y69.37% Inst Trans153.97% Short Interest0.42M Perf Half Y164.23%
Book/sh0.25 P/B3.67 EPS next Y17.65% ROA-106.34% Target Price- Perf Year132.01%
Cash/sh0.24 P/C3.88 EPS next 5Y- ROE-128.07% 52W Range0.22 - 2.42 Perf YTD291.86%
Dividend- P/FCF- EPS past 5Y-44.30% ROI-161.51% 52W High-61.79% Beta2.00
Dividend %- Quick Ratio10.02 Sales past 5Y0.00% Gross Margin- 52W Low322.38% ATR0.11
Employees4 Current Ratio10.02 Sales Q/Q- Oper. Margin0.00% RSI (14)39.32 Volatility7.48% 9.72%
OptionableYes Debt/Eq0.00 EPS Q/Q82.21% Profit Margin- Rel Volume0.21 Prev Close0.96
ShortableYes LT Debt/Eq0.00 EarningsAug 10 BMO Payout- Avg Volume589.54K Price0.92
Recom- SMA20-6.81% SMA50-29.44% SMA2002.37% Volume124,573 Change-3.67%
Sep-18-23 07:05AM
Sep-12-23 07:05AM
Aug-15-23 07:48AM
Aug-14-23 07:05AM
Aug-12-23 09:40AM
07:05AM Loading…
Aug-10-23 07:05AM
Aug-09-23 07:05AM
Aug-03-23 04:05PM
Jul-24-23 08:40AM
Jul-17-23 02:20PM
May-25-23 04:05PM
May-16-23 10:26AM
May-15-23 07:05AM
May-11-23 07:49AM
07:39AM Loading…
May-04-23 07:05AM
Apr-25-23 01:07PM
Apr-24-23 04:15PM
Mar-16-23 07:10AM
Mar-14-23 07:05AM
Mar-07-23 07:05AM
Feb-13-23 07:05AM
Jan-05-23 07:00AM
Dec-05-22 08:30AM
Nov-29-22 07:05AM
Nov-22-22 06:15AM
Nov-14-22 07:05AM
Nov-03-22 07:05AM
07:27AM Loading…
Sep-23-22 07:27AM
Sep-22-22 04:15PM
Sep-19-22 10:04PM
Sep-16-22 09:30AM
Sep-12-22 09:30AM
Sep-05-22 06:47AM
Aug-15-22 07:24AM
Aug-11-22 07:05AM
Aug-10-22 04:01PM
Aug-08-22 08:30AM
Aug-04-22 07:05AM
Jul-26-22 08:30AM
Jul-19-22 08:30AM
Jun-01-22 07:05AM
May-17-22 12:05PM
May-12-22 07:05AM
May-05-22 07:05AM
Apr-28-22 07:05AM
Mar-28-22 07:10PM
Mar-21-22 06:25AM
Mar-17-22 07:05AM
Mar-10-22 07:05AM
Mar-08-22 04:05PM
Feb-28-22 07:05AM
Feb-01-22 03:00AM
Jan-26-22 04:30PM
Jan-04-22 04:05PM
Dec-01-21 07:05AM
Nov-15-21 07:34AM
Nov-11-21 07:05AM
Nov-04-21 07:05AM
Sep-28-21 03:33PM
Sep-08-21 07:05AM
Sep-02-21 07:05AM
Aug-19-21 07:05AM
Aug-16-21 08:30AM
Aug-12-21 07:05AM
Aug-11-21 07:05AM
Aug-09-21 07:05AM
Aug-05-21 07:05AM
Jul-26-21 07:05AM
Jul-08-21 11:44AM
Jun-21-21 07:13AM
Jun-15-21 06:41AM
Jun-09-21 08:40AM
Jun-04-21 07:05AM
Jun-03-21 05:43AM
Jun-02-21 07:05AM
May-24-21 07:05AM
May-18-21 07:31AM
May-13-21 07:05AM
May-07-21 07:05AM
May-06-21 07:05AM
Apr-16-21 07:05AM
Apr-07-21 07:05AM
Mar-30-21 09:29AM
Mar-18-21 07:05AM
Mar-11-21 07:05AM
Feb-24-21 07:05AM
Virios Therapeutics, Inc. develops pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1, a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pridgen WilliamDirectorAug 21Buy1.3015,33519,99252,045Aug 22 03:57 PM
Duncan Gregory ScottCHIEF EXECUTIVE OFFICERAug 17Buy1.2525,00031,24557,461Aug 18 07:05 AM
Whitley Richard JamesDirectorDec 08Sale0.261,800466700Dec 12 01:39 PM